Researchers’ from National Taiwan University Report Details of New Studies and Findings in the Area of Chronic Kidney Disease (Effect of a Pay-for-Performance Program on Renal Outcomes Among Patients With Early-Stage Chronic Kidney Disease in …): Kidney Diseases and Conditions – Chronic Kidney Disease

2023 MAR 20 (NewsRx) -- By a News Reporter-Staff News Editor at Taiwan Daily Report -- Current study results on chronic kidney disease have been published. According to news originating from Taipei, Taiwan, by NewsRx correspondents, research stated, “With the promising outcomes of the pre-ESRD (end-stage renal disease) pay-for-performance (P4P) program, the National Health Insurance Administration (NHIA) of Taiwan launched a P4P program for patients with early chronic kidney disease (CKD) in 2011, targeting CKD patients at stages 1, 2, and 3a. This study aimed to examine the long-term effect of the early-CKD P4P program on CKD progression.”

Our news reporters obtained a quote from the research from National Taiwan University: “We conducted a matched cohort study using electronic medical records from a large healthcare delivery system in Taiwan. The outcome of interest was CKD progression to estimated glomerular filtration rate (eGFR) 2 between P4P program enrolees and non-enrolees. The difference in the cumulative incidence of CKD progression between the P4P and non-P4P groups was tested using Gray’s test. We adopted a cause-specific (CS) hazard model to estimate the hazard in the P4P group as compared to non-P4P group, adjusting for age, sex, baseline renal function, and comorbidities. A subgroup analysis was further performed in CKD patients with diabetes to evaluate the interactive effects between the early-CKD P4P and diabetes P4P programs. The incidence per 100 person-months of disease progression was significantly lower in the P4P group than in the non-P4P group (0.44 vs. 0.69, P < .0001), and the CS hazard ratio (CS-HR) for P4P program enrolees compared with non-enrolees was 0.61 (95% CI: 0.58-0.64, P < .0001). The results of the subgroup analysis further revealed an additive effect of the diabetes P4P program on CKD progression; compared to none of both P4P enrolees, the CS-HR for CKD disease progression was 0.60 (95% CI: 0.54-0.67, P < .0001) for patients who were enrolled in both early-CKD P4P and diabetes P4P programs.”

According to the news editors, the research concluded: “The present study results suggest that the early-CKD P4P program is superior to usual care to decelerate CKD progression in patients with early-stage CKD.”

For more information on this research see: Effect of a Pay-for-Performance Program on Renal Outcomes Among Patients With Early-Stage Chronic Kidney Disease in Taiwan. International Journal of Health Policy and Management, 2022,11(8):1307-1315. (International Journal of Health Policy and Management - http://www.ijhpm.com/). The publisher for International Journal of Health Policy and Management is Kerman University of Medical Sciences.

A free version of this journal article is available at https://doi.org/10.34172/ijhpm.2021.27.

Our news journalists report that more information may be obtained by contacting Min-Ting Lin, Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan. Additional authors for this research include Chien-Ning Hsu, Chien-Te Lee, Shou-Hsia Cheng.

(Our reports deliver fact-based news of research and discoveries from around the world.)